Loss of function experiments in pancreatic cancer cell lines demonstrated that HOXB6 and HOXB8 control cancer cell proliferation, viability, apoptosis, senescence, and sensitivity to gemcitabine. This evidence concerns the gene HOXB6 and familial pancreatic carcinoma.